First Page | Document Content | |
---|---|---|
Date: 2005-10-17 17:52:11Cardiac electrophysiology Circulatory system Piperazines QT interval Channelopathy Syndromes Long QT syndrome HERG Torsades de pointes Cardiac dysrhythmia Chemistry Physiology | Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic DrugsAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 66,91 KBShare Document on Facebook |